About Us
REVOLUTIONIZING GLOBAL HEALTHCARE WITH AI-DRIVEN DRUG DISCOVERY AND DEVELOPMENT
Accelerating Breakthroughs in Medicine with AlphaMeld
InveniAI Over the Years
Our journey began over a decade ago to solve real-world problems for the pharmaceutical industry. Effectively utilizing available information is central to staying innovative in data and research-dependent industries. In response, we created an industry-leading technology platform – AlphaMeld®, which has been crucial in delivering significant clinical, transactional, and strategic impact for over 150 biopharma industry collaborations. This has solidified the value of using AI technology to guide and expedite the discovery and development of meaningful solutions across all therapeutic areas and modalities.
In 2017, the parent company, BioXcel LLC (Est 2005), spun out InveniAI to focus on AI applications for drug discovery and development and our sister company, BioXcel Therapeutics, to focus on developing neuroscience and immuno-oncology programs.
We boast a global, robust, and diverse team of handpicked domain experts including translational, clinical, commercial, AI, and IT experts who work across our offices in Guilford, CT, Basel, Switzerland, and India. Our team is wholly focused on building and enhancing the development of our platform to expedite the discovery and advancement of healthcare products and technologies. Our team resolutely believes in the power of AI-technology to capture innovation and bring about expedited transformational therapies and products to the market.
Who We Are
We are a global leader in leveraging AI, machine learning, and generative AI to revolutionize drug discovery and development. Guided by our mission to identify and accelerate transformative therapies for diseases with unmet medical needs, we harness the power of our cutting-edge AlphaMeld® platform to extract insights from vast and diverse data sets. This innovative approach drives the creation of groundbreaking drug programs and fosters successful collaborations with industry leaders. As trailblazers in AI-driven drug discovery, we continue to catalyze innovation and redefine possibilities in healthcare.
Culture and Commitment
At AlphaMeld® Corporation, we embrace diversity and combine technology with human expertise to drive healthcare innovation. Our mission is to improve patients’ lives by addressing enduring healthcare challenges. We foster a collaborative, team-oriented environment built on trust, motivation, and shared goals, nurturing future leaders who understand their impact on others. Together, we create a vibrant workplace centered on diversity, learning, and innovation.